The results from this study suggests that HAS2 overexpression, post-lung injury, leads to dysregulated CD44–HA signaling, resulting in a signaling environment conducive to fibroblast activation and invasion leading to the development of IPF. Here, CD44 is linked to idiopathic pulmonary fibrosis.